SCureClamp-KO copy.png
 

Simple, Secure Occlusion

 
AmselVO-header.jpg

CE mark and FDA cleared SCureClamp™ with Interdigitation Occlusion Technology (iDOT™) is designed to easily and securely close vessels – veins, arteries, and tubular structures – during surgical and interventional procedures.

 

This unique mechanical surgical clamping technology is delivered directly through a fine, minimally invasively, 18 G needle for clamping of blood vessels, ducts, arteries, and veins. The minimally invasive needle delivery results in secure occlusion similar to that of a transfixion suture.

SCureClamp with iDOT’s anchoring feature secures the implant in place and eliminates slippage. Grasping allows physicians to occlude vessels of varying sizes, types and wall thickness.

Design Features:

  • Permanent
  • Non-Chemical
  • Non-Thermal
  • Non-Tumescent
  • No Compression
  • Ultrasound Guided
  • Targeting 18 G Needle Delivery
 
clip-needle.jpg

FDA Indication for Use:

FDA Indication for use: The Amsel Occluder Device is intended for use in open general surgery procedures on tubular structures or vessels wherever a metal ligation clip is indicated and within the size range of 2.0mm to 7.00mm diameter.

FDA.png

CE Mark Indication for Use:

The Amsel Occluder device and its appliers are intended for use on tubular structures or vessels wherever a metal ligating clip is indicated. The tissue being ligated should be consistent with the size of the clip.

PastedGraphic-1.png
 

Watch to Learn More

data1@2x.png
data2.png
data3.png
greybluelight.png
 

Peer Reviewed Publications

Journal of Vascular Surgery

A preclinical animal study of a novel, simple, and secure percutaneous vessel occluder for the treatment of varicose veins

This study confirms that the SCureClamp with iDOT can be effectively delivered percutaneously under ultrasound guidance toocclude blood vessels in the porcine model and may be a useful, time-saving, and cost-effective adjunct to current primary methods of treating…

Journal of Surgical Endoscopy

A preclinical animal study of a novel, simple, and secure duct and vessel occluder for laparoscopic surgery

The SCureClamp with iDOT delivered laparoscopically provides an occlusion similar to a hand-sewn transfixion suture, is simple to use, and creates an occlusion which is not only more secure, but also as safe with respect to the health of the surrounding tissues, as that of the widely used hemoclip (Ligaclip®).

Journal of Surgical Research

A novel secure transfixing blood vessel occluder: comparison with the hemoclip in the porcine model

The SCureClamp with iDOT is simple to deploy and securely maintains occlusion by transfixing the targeted vessel, unlike the widely used, nontransfixing Ligaclip, that has a tendency to dislodge. As such, the SCureClamp with iDOT opens up numerous treatment opportunities in…

 
 

Specialties

VASCULAR

amsel_inuse

Current treatments for venous disease do not typically provide a permanent solution. Without effective occlusion, physicians are seeing ulcer recurrence, rising costs, and severe patient morbidity.

Perforator treatments such as lasers, RF, glue, and sclerotheray average a 75-80% efficacy rate.


The veins in your body play an important role in circulation, carrying blood from your various parts of your body back to your heart. Yet, as people age, problems can develop in the veins and cause a variety of complications. In fact, one in three Americans over the age of 45 has some kind of vein disease.

Early symptoms may seem minor. However, they can become more serious – and even life-threatening – if they are not treated. Which is why it is important to be aware of symptoms and seek medical advice at the earliest sign of a problem.

Source: veinforum.org


Amsel_medical_trauma

87% of military fatalities occur in the prehospital environment

TRAUMA: MILITARY

The temporary clamping device is targeted at reducing front-line deaths associated with non-compressible and junctional hemorrhage, which currently accounts for a staggering 60% of fatalities in military trauma cases. Current data shows that 87% of military fatalities occur in the prehospital environment, proving the need for an accessible, portable, minimally invasive, and effective tool to aid in the urgent care of those wounded.

Currently Under Development:

afwerx.png

SURGICAL APPLICATIONS

There are numerous general surgical applications for the SCureClamp with iDOT, including bariatric, cardiac and oncology.

  • Vein Physicians
  • General Surgeons
  • Vascular Surgeons
  • Cardiovascular Surgeons
  • Interventional Radiologists
  • Military Medical Personnel/Emergency Medical Technicians
AdobeStock_150608240.jpeg
 
grey.png
 

From the Field

 
The SCureClamp possesses the ability to transfix and ligate a selected vessel, advancing our technique beyond the current limitations of standard ligation clips.
— HILLEL LAKS, CHANCELLORS PROFESSOR OF SURGERY, UCLA MEDICAL CENTER
 
The SCureClamp represents a fresh approach to facilitating accurate, complete and secure vessel closure.
— TOM O'DONNELL, FORMER PRESIDENT & CEO OF TUFTS MEDICAL